Lindsay J. Celada, Ph.D.

Research Instructor

lindsay.j.celada@vanderbilt.edu
Faculty Appointments
Research Instructor in Medicine
Education
Ph.D., Immunology, Tennessee State University, Nashville, TennesseeB.S., David Lipscomb University, Nashville, Tennessee
Publications
Celada LJ, Rotsinger JE, Young A, Shaginurova G, Shelton D, Hawkins C, Drake WP. Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation. Am. J. Respir. Cell Mol. Biol. 2017 Jan; 56(1): 74-82. PMID: 27564547, PMCID: PMC5248958, DOI: 10.1165/rcmb.2016-0037OC, ISSN: 1535-4989.

Hawkins C, Shaginurova G, Shelton DA, Herazo-Maya JD, Oswald-Richter KA, Rotsinger JE, Young A, Celada LJ, Kaminski N, Sevin C, Drake WP. Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis. J Immunol Res [print-electronic]. 2017; 2017: 3642832. PMID: 29234685, PMCID: PMC5695030, DOI: 10.1155/2017/3642832, ISSN: 2314-7156.

Rotsinger JE, Celada LJ, Polosukhin VV, Atkinson JB, Drake WP. Molecular Analysis of Sarcoidosis Granulomas Reveals Antimicrobial Targets. Am. J. Respir. Cell Mol. Biol. 2016 Jul; 55(1): 128-34. PMID: 26807608, PMCID: PMC4942207, DOI: 10.1165/rcmb.2015-0212OC, ISSN: 1535-4989.

Celada LJ, Hawkins C, Drake WP. The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis. Clin. Chest Med [print-electronic]. 2015 Dec; 36(4): 561-8. PMID: 26593133, PMCID: PMC4660257, PII: S0272-5231(15)00101-X, DOI: 10.1016/j.ccm.2015.08.001, ISSN: 1557-8216.

Celada LJ, Drake WP. Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?. Immunotherapy. 2015; 7(1): 57-66. PMID: 25572480, DOI: 10.2217/imt.14.103, ISSN: 1750-7448.

Cato A, Celada L, Kibakaya EC, Simmons N, Whalen MM. Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells. Cell Biol. Toxicol [print-electronic]. 2014 Dec; 30(6): 345-60. PMID: 25341744, PMCID: PMC4246052, DOI: 10.1007/s10565-014-9289-y, ISSN: 1573-6822.

Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM, Grutters J, Culver DA, Dworski R, Sheller J, Massion PP, Polosukhin VV, Johnson JE, Kaminski N, Wilkes DS, Oswald-Richter KA, Drake WP. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am. J. Respir. Crit. Care Med. 2014 Sep 9/1/2014; 190(5): 560-71. PMID: 25073001, PMCID: PMC4214083, DOI: 10.1164/rccm.201401-0188OC, ISSN: 1535-4970.

Celada LJ, Whalen MM. Effects of butyltins on mitogen-activated-protein kinase kinase kinase and Ras activity in human natural killer cells. J Appl Toxicol [print-electronic]. 2014 Sep; 34(9): 1002-11. PMID: 24038145, PMCID: PMC3868639, DOI: 10.1002/jat.2921, ISSN: 1099-1263.